Solstice Advanced Materials, Inc.

Solstice Advanced Materials, Inc. Earnings Recaps

SOLS Materials 3 recaps
Next earnings: February 10, 2027 (estimated) · full calendar
Q3 2026 Nov 7, 2026

Solstice shares fell 6.5% despite the company raising full-year 2026 guidance. The transcript does not identify a specific cause for the selloff; the clearest potential concern is that nuclear sales faced previously communicated product loan returns, tempering otherwise positive growth commentary.

Key takeaways
  • Third-quarter net sales rose 8%, which management said was above the top end of its guidance range; electronic materials, refrigerants, and health care packaging led growth.
  • Nuclear demand indicators were positive, with backlog at $2.6 billion and contracts extending through 2039, but results were affected by product loan returns.
  • Data center and AI-related applications represent approximately 6% of expected 2026 revenue, with sales up more than 50% year over year.
  • Solstice repurchased $100 million of shares in the quarter and intends to substantially complete the remaining $400 million authorization by the end of Q1 2027.
  • The company completed its remaining legacy Honeywell transition service agreements ahead of schedule and under budget.
Q2 2026 Aug 1, 2026

Solstice Advanced Materials delivered better-than-expected top and bottom line results, with revenue and adjusted EBITDA surpassing guidance, driving an 8.1% stock rally. Investors responded positively to strong demand momentum across key segments and raised full-year guidance.

Key takeaways
  • Q2 net sales grew 11% year-over-year to $1.148 billion, exceeding the high end of guidance.
  • Adjusted EBITDA rose 2% year-over-year to $290 million, also above guidance, with margin stable at 25.3%.
  • Growth driven by strong demand in Refrigerants & Applied Solutions (notably HFO refrigerants and data center orders) and Electronic & Specialty Materials (semiconductor applications).
  • GAAP net income reached $119 million, up from $97 million last year; adjusted EPS was $0.88.
  • Free cash flow for H1 2026 was $248 million despite increased growth CapEx to support strategic investments and expansion projects.
Q1 2026 May 7, 2026

Solstice’s stock declined 6.9% following the quarter, reflecting investor disappointment with margin compression due to refrigerant mix and elevated R&D spending, despite top-line growth and solid cash flow.

Key takeaways
  • Net sales increased 10% year-over-year to $991 million, driven by robust demand in Electronic Materials and Refrigerants & Applied Solutions segments.
  • Adjusted EBITDA was flat year-over-year at $249 million, with a 25.1% margin, down primarily due to a mix shift toward lower-margin refrigerants and higher R&D investments.
  • GAAP net income declined to $85 million, impacted by higher SG&A and interest expenses as a stand-alone public company.
  • Adjusted diluted EPS came in at $0.63 for the first quarter.
  • Free cash flow totaled $124 million, despite a significant rise in growth CapEx, including a $200 million investment to expand sputtering target capacity.